LAG3 and neoplasm: However, when looking at the expression level, we observed relatively high expression of LAG3 and HAVCR2 in both primary and recurrent tumor and a trend of greater expression for TIGIT, CTLA4, BTLA, and PDCD1 in recurrent tumor tissue, compared to primary tumor tissue (NS) (Figure 5F).